949PFirst-line pembrolizumab (pembro) monotherapy in...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

949PFirst-line pembrolizumab (pembro) monotherapy in advanced clear cell renal cell carcinoma (ccRCC): Updated follow-up for KEYNOTE-427 cohort A

Larkin, J M G, Tykodi, S S, Donskov, F, Lee, J-L, Szczylik, C, Malik, J, Alekseev, B Y, Matveev, V B, Gafanov, R A, Tomczak, P, Geertsen, P F, Wiechno, P J, Shin, S J, Pouliot, F, Alonso Gordoa, T, Kl
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz249.045
Date:
October, 2019
File:
PDF, 92 KB
2019
Conversion to is in progress
Conversion to is failed